<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02291081</url>
  </required_header>
  <id_info>
    <org_study_id>12-4970-BO A</org_study_id>
    <nct_id>NCT02291081</nct_id>
  </id_info>
  <brief_title>A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients</brief_title>
  <acronym>HIV-HEART10</acronym>
  <official_title>A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk, New Cardiovascular Events and the Cardiovascular Diseases in HIV-infected Patients: 10 Year Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nico Reinsch M. D.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Till Neumann Prof. M. D.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HIV/HEART study (HIVH) is an ongoing, prospective, multicentre trial that was conducted
      to assess the incidence, the prevalence and the clinical course of cardiovascular diseases
      (CVD) in HIV-infected patients. The study population includes outpatients from specialized
      HIV-care units of the German Ruhr region, who were at least 18 years of age, were known to
      have a HIV-infection and exhibited a stable disease status within 4 weeks before inclusion
      into the trial. From March 2004 (Pilot phase) to May 2014 (7,5 year Follow-up) 1481 HIV+
      patients were recruited in a consecutive manner. The standardised examinations included a
      targeted assessment of medical history and physical examination. Blood was drawn for
      comprehensive laboratory tests including HIV specific parameters (CD4 cell count, HIV-1 RNA
      levels) and cardiovascular items (lipid concentrations, BNP values and renal parameters).
      Furthermore, non-invasive tests were performed during the initial visit, including additional
      heart rate and blood pressure measurements, electrocardiogram (ECGs) and transthoracic
      echocardiography (TTE). Examinations were completed in accordance with previously defined
      standard operating procedures. CVD were defined as coronary, cerebrovascular, peripheral
      arterial disease, heart failure or cardiac vitium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A comprehensive detailed description of the study procedures had been previously published
      (European Journal of medical research 2007;12:243-248).

      Comprehensive non invasive cardiovascular examination

        -  Anamnesis

        -  File recherche,Physical examination

        -  Documentation of the cardiovascular and antiretroviral medical therapy

        -  Electrocardiogram

        -  Transthoracic echocardiography

        -  Exercise electrocardiogram

        -  Exercise Montreal Cognitive Assessment test

        -  Exercise the Grooved Pegboard test

        -  Blood collection

        -  Questionnaire to quality of life and health economics
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular Diseases an deaths in HIV-infected Patients</measure>
    <time_frame>Baseline up to 10 year follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of classic cardiovascular risk factors and new HIV-specific risk factors of coronary artery disease, comorbidities and antiretroviral therapy</measure>
    <time_frame>Baseline up to 10 year follow-up</time_frame>
    <description>Patients included in the pilot-baseline trial and additionally in the 5 and 7.5 year follow-up will be recruited again for the 10 year follow-up after giving informed consent. After including a total of 1481 patients in the previous phases, now both therapy-naive patients as well as patients being treated with new agents should be included.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>HIV-infection</condition>
  <condition>Coronary Heart Disease</condition>
  <condition>Myocardial Infarction</condition>
  <condition>HIV-encephalopathy</condition>
  <condition>Heart Failure</condition>
  <condition>Aging</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comprehensive non invasive cardiovascular examination</intervention_name>
    <description>Comprehensive non invasive cardiovascular examination
Anamnesis with the participants
File recherche,Physical examination
Documentation of the cardiovascular and antiretroviral medical therapy
Electrocardiogram
Transthoracic echocardiography
Exercise electrocardiogram
Exercise Montreal Cognitive Assessment test
Exercise the Grooved Pegboard test
Blood collection
Questionnaire to quality of life and health economics</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stored blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participiants were included in several cities of the Ruhrarea. Locations were Essen,
        Bochum, Dortmund and Duisburg The study population included outpatients who were at least
        18 years of age, had a known HIV-infection and exhibited a stable disease status within 4
        weeks before inclusion of the trial. Written informed consent was obtained from all
        participants.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Known HIV-infection

          -  Written informed consent

        Exclusion Criteria:

          -  Acute cardiovascular disease

          -  Unstable hemodynamic status in the three weeks before inclusion

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Esser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Depatment of dermatology and venerology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Esser, MD</last_name>
    <phone>00492017233878</phone>
    <phone_ext>3845</phone_ext>
    <email>stefan.esser@uk-essen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nico Reinsch, MD</last_name>
    <phone>004920172384805</phone>
    <email>nico.reinsch@uk-essen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Bochum, Department of Dermatology</name>
      <address>
        <city>Bochum</city>
        <state>NRW</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Norbert H Brockmeyer, MD</last_name>
      <phone>00492345093471</phone>
      <email>n.brockmeyer@derma.de</email>
    </contact>
    <contact_backup>
      <last_name>Wolfgang Fuchs, MD</last_name>
      <phone>00492345092234</phone>
      <email>W.Fuchs@klinikum-bochum.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>City Hospital Dortmund</name>
      <address>
        <city>Dortmund</city>
        <state>NRW</state>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Hower, MD</last_name>
      <phone>004995320700</phone>
      <email>ID.ambulanz@klinikumdo.de</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Bachmann, Study Nurse</last_name>
      <phone>004995320700</phone>
      <email>ID.ambulanz@klinikumdo.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HIV physician pratice</name>
      <address>
        <city>Duisburg</city>
        <state>NRW</state>
        <zip>47259</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Friedhelm Kwirant, MD</last_name>
      <phone>0049203782173</phone>
      <email>FKwirant@t-online.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital, Department of Dermatology and Venerology</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Esser, MD</last_name>
      <phone>00492017233878</phone>
      <email>stefan.esser@uk-essen.de</email>
    </contact>
    <contact_backup>
      <last_name>Nico Reinsch, MD</last_name>
      <phone>004920172384805</phone>
      <email>nico.reinsch@uk-essen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Stefan Esser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HIV physician practice</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Rudolph, MD</last_name>
      <phone>0049201223638</phone>
      <email>dr.r.rudolph@web.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HIV physician practice</name>
      <address>
        <city>Krefeld</city>
        <state>NRW</state>
        <zip>47799</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter A Arbter, MD</last_name>
      <phone>0049215121807</phone>
      <email>arbter@arbter.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Coordinating Center Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04107</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Neumann T, Woiwod T, Neumann A, Miller M, Von Birgelen C, Volbracht L, Esser S, Brockmeyer N, Gerken G, Erbel R. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age differences. Eur J Med Res. 2004 May 28;9(5):267-72.</citation>
    <PMID>15257881</PMID>
  </results_reference>
  <results_reference>
    <citation>Breuckmann F, Nassenstein K, Kondratieva J, Esser S, Erbel R, Potthoff A, Brockmeyer NH, Neumann T, Barkhausen J; German Heart Failure Network; Competence Network HIV/AIDS. MR characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels. Eur J Med Res. 2007 May 29;12(5):185-90.</citation>
    <PMID>17513188</PMID>
  </results_reference>
  <results_reference>
    <citation>Neumann T, Esser S, Potthoff A, Pankuweit S, Neumann A, Breuckmann F, Neuhaus K, Kondratieva J, Buck T, Müller-Tasch T, Wachter R, Prettin C, Gelbrich G, Herzog W, Pieske B, Rauchhaus M, Löffler M, Maisch B, Mügge A, Wasem J, Gerken G, Brockmeyer NH, Erbel R; HIV-HEART Study Investigative Group. Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res. 2007 Jun 27;12(6):243-8.</citation>
    <PMID>17666313</PMID>
  </results_reference>
  <results_reference>
    <citation>Potthoff A, Brockmeyer NH, Gelbrich G, Neuhaus K, Esser S, Reinsch N, Hower M, Mostardt S, Neumann A, Neumann T; Competence Center Cardiac Insufficiency and the Competence Network HIV/AIDS. Lipodystrophy - a sign for metabolic syndrome in patients of the HIV-HEART study. J Dtsch Dermatol Ges. 2010 Feb;8(2):92-8. doi: 10.1111/j.1610-0387.2009.07330.x. Epub 2009 Dec 14. English, German.</citation>
    <PMID>20002869</PMID>
  </results_reference>
  <results_reference>
    <citation>Neumann T, Reinsch N, Neuhaus K, Brockmeyer N, Potthoff A, Esser S, Hower M, Neumann A, Mostardt S, Gelbrich G, Erbel R; für die HIV-HEART-Studie sowie die Kompetenznetze Herzinsuffizienz und HIV/AIDS. [BNP in HIV-infected patients]. Herz. 2009 Dec;34(8):634-40. doi: 10.1007/s00059-009-3313-7. German.</citation>
    <PMID>20024643</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, Erbel R, Neumann T; German Competence Network for Heart Failure; German Competence Network for HIV AIDS. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2010 May-Jun;11(3):156-62. doi: 10.1310/hct1103-156.</citation>
    <PMID>20739268</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Mostardt S, Neumann A, Brockmeyer NH, Gelbrich G, Erbel R, Neumann T; German Competence Network Heart Failure; German Competence Network for HIV/AIDS. Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study. Eur J Prev Cardiol. 2012 Apr;19(2):267-74. doi: 10.1177/1741826711398431. Epub 2011 Feb 28.</citation>
    <PMID>21450595</PMID>
  </results_reference>
  <results_reference>
    <citation>Gelbrich B, Neumann T, Esser S, Potthoff A, Reinsch N, Hower M, Dannhauer KH, Loeffler M, Brockmeyer NH, Erbel R, Gelbrich G; HIV-HEART Study Investigative Group, Competence Networks Heart Failure and HIV/AIDS. Oral health and the heart - does HIV infection open a pathophysiological gateway? Int J Cardiol. 2011 Sep 1;151(2):254-7. doi: 10.1016/j.ijcard.2011.06.081. Epub 2011 Jul 18.</citation>
    <PMID>21764468</PMID>
  </results_reference>
  <results_reference>
    <citation>Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N. Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. Clin Res Cardiol. 2013 Mar;102(3):203-13. doi: 10.1007/s00392-012-0519-0. Epub 2012 Nov 2.</citation>
    <PMID>23117698</PMID>
  </results_reference>
  <results_reference>
    <citation>Lind A, Reinsch N, Neuhaus K, Esser S, Brockmeyer NH, Potthoff A, Pankuweit S, Erbel R, Maisch B, Neumann T. Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy. Eur J Med Res. 2011 Nov 10;16(11):480-3.</citation>
    <PMID>22027640</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinsch N, Kahlert P, Esser S, Sundermeyer A, Neuhaus K, Brockmeyer N, Potthoff A, Erbel R, Buck T, Neumann T. Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study. Am J Cardiovasc Dis. 2011;1(2):176-84. Epub 2011 Jul 30.</citation>
    <PMID>22254197</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2014</study_first_submitted>
  <study_first_submitted_qc>November 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2014</study_first_posted>
  <last_update_submitted>November 11, 2014</last_update_submitted>
  <last_update_submitted_qc>November 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Stefan Esser M.D.</investigator_full_name>
    <investigator_title>Academic director</investigator_title>
  </responsible_party>
  <keyword>HIV, AIDS</keyword>
  <keyword>antiretroviral therapy</keyword>
  <keyword>aging</keyword>
  <keyword>heart failure</keyword>
  <keyword>coronary heart disease</keyword>
  <keyword>myocardial infarction</keyword>
  <keyword>HIV-associated neurocognitive disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>AIDS Dementia Complex</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

